Performance of a rapid recency assay for detection of early HIV infection.
Clara Di GermanioXutao DengEduard GrebeJeffrey A JohnsonSilvina MasciotraMichael P BuschPhilip J NorrisPublished in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology (2024)
The Asanté HIV-1 Rapid Recency assay's 'verification' line detected HIV infection a median of 18 days later than a nucleic acid detection assay and performed similarly to 19 other existing rapid HIV antibody tests. Pending regulatory approval, the assay could be an option with other rapid tests in national HIV-1 testing algorithms, which would allow collection of HIV recency data as part of a national screening program without requiring additional testing.
Keyphrases
- hiv testing
- loop mediated isothermal amplification
- antiretroviral therapy
- men who have sex with men
- hiv positive
- hiv infected
- high throughput
- human immunodeficiency virus
- quality improvement
- hiv aids
- nucleic acid
- sensitive detection
- hepatitis c virus
- machine learning
- transcription factor
- electronic health record
- label free
- artificial intelligence